why choose us

First received: September 11, 2024

Clinical Trial: A Study in Participants With Obesity or Overweight With at Least One Weight-related Comorbidity

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Obesity or Overweight

Study Type: INTERVENTIONAL


Official Title: A Phase IIb Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Obesity or Overweight With Comorbidity

Brief Summary: A Phase IIb Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of AZD6234 compared with placebo, given once a week as subcutaneous injection for 36 weeks, in male and female participants of at least 18 years of age who are living with obesity (body mass index [BMI] ? 30 kg/m2), or overweight (BMI ? 27 kg/m2) and at least one weight-related comorbidity

Read more